Lv4
720 积分 2023-01-09 加入
The evolving landscape of obesity pharmacotherapy
22天前
已完结
The Role of Dehydroascorbate in Disulfide Bond Formation
1个月前
已完结
Cell‐Permeable Peptides Containing Cycloalanine Residues
1个月前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
1个月前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
1个月前
已完结
Structure, Self-Association, and Aggregation Properties of a Long-Acting Amylin Receptor Agonist
1个月前
已完结
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes
1个月前
已完结
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
1个月前
已完结
Development of a Long-Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP-1R Agonists for the Treatment of Obesity
1个月前
已完结
Adding a C‐terminal amino acid prevents the conformational interconversion of plecanatide analogues
1个月前
已完结
皖公网安备34019202002308
